Cargando…

原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342446/
https://www.ncbi.nlm.nih.gov/pubmed/31648480
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.09.011
_version_ 1783555489162854400
collection PubMed
description
format Online
Article
Text
id pubmed-7342446
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73424462020-07-16 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2019-09 /pmc/articles/PMC7342446/ /pubmed/31648480 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.09.011 Text en 2019年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
title 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
title_full 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
title_fullStr 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
title_full_unstemmed 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
title_short 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
title_sort 原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342446/
https://www.ncbi.nlm.nih.gov/pubmed/31648480
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.09.011
work_keys_str_mv AT yuányányīmǎtìníhuòníluòtìnízhuǎnhuànguóchǎnyīmǎtìnízhìliáomànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěyǒuxiàoxìngānquánxìnghéshēnghuózhìliàngyánjiū
AT yuányányīmǎtìníhuòníluòtìnízhuǎnhuànguóchǎnyīmǎtìnízhìliáomànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěyǒuxiàoxìngānquánxìnghéshēnghuózhìliàngyánjiū
AT yuányányīmǎtìníhuòníluòtìnízhuǎnhuànguóchǎnyīmǎtìnízhìliáomànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěyǒuxiàoxìngānquánxìnghéshēnghuózhìliàngyánjiū
AT yuányányīmǎtìníhuòníluòtìnízhuǎnhuànguóchǎnyīmǎtìnízhìliáomànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěyǒuxiàoxìngānquánxìnghéshēnghuózhìliàngyánjiū
AT yuányányīmǎtìníhuòníluòtìnízhuǎnhuànguóchǎnyīmǎtìnízhìliáomànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěyǒuxiàoxìngānquánxìnghéshēnghuózhìliàngyánjiū
AT yuányányīmǎtìníhuòníluòtìnízhuǎnhuànguóchǎnyīmǎtìnízhìliáomànxìngsuǐxìngbáixuèbìngmànxìngqīhuànzhěyǒuxiàoxìngānquánxìnghéshēnghuózhìliàngyánjiū